Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Michelle A Berny-Lang; Sawan Hurst; Erik I Tucker; Leslie A Pelc; Ruikang K Wang; Patricia D Hurn; Enrico Di Cera; Owen J T McCarty; András Gruber

doi:10.1161/STROKEAHA.110.603811

Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Identifier:nobleid.org/w1/20260515/267402CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/267402CD.svg?ark=w1%2F20260515%2F267402CD)](https://nobleid.org/work/w1/20260515/267402CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Michelle A Berny-Lang

Claim authorship of this work

Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.

Identifier:nobleid.org/w1/20260515/267402CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/267402CD.svg?ark=w1%2F20260515%2F267402CD)](https://nobleid.org/work/w1/20260515/267402CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Michelle A Berny-Lang

Claim authorship of this work